Stifel analysts maintained a positive outlook on MaxLinear shares (NASDAQ:MXL), reiterating a Buy rating and a price target ...
Stifel analysts reiterated a Buy rating on Bicara Therapeutics Inc (NASDAQ:BCAX), maintaining a $47.00 price target. Trading ...
Brown & Brown Inc (BRO), Nucor Corp (NUE), W R Berkley Corp (WRB). On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in ...